KPRX
Price:
$3.27
Market Cap:
$9.81M
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patient...[Read more]
Industry
Biotechnology
IPO Date
2015-02-13
Stock Exchange
NASDAQ
Ticker
KPRX
According to Kiora Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.25M. This represents a change of -89.65% compared to the average of 41.06M of the last 4 quarters.
The mean historical Enterprise Value of Kiora Pharmaceuticals, Inc. over the last ten years is 154.39M. The current 4.25M Enterprise Value has changed 175.16% with respect to the historical average. Over the past ten years (40 quarters), KPRX's Enterprise Value was at its highest in in the December 2014 quarter at 377.84M. The Enterprise Value was at its lowest in in the September 2024 quarter at 9.86M.
Average
154.39M
Median
135.03M
Minimum
180.84K
Maximum
377.84M
Discovering the peaks and valleys of Kiora Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 101.50%
Maximum Annual Enterprise Value = 377.84M
Minimum Annual Increase = -98.92%
Minimum Annual Enterprise Value = 180.84K
Year | Enterprise Value | Change |
---|---|---|
2023 | 180.84K | -98.92% |
2022 | 16.75M | -86.43% |
2021 | 123.42M | -39.17% |
2020 | 202.90M | -28.35% |
2019 | 283.17M | 101.50% |
2018 | 140.53M | 8.49% |
2017 | 129.53M | 2.81% |
2016 | 125.99M | -12.27% |
2015 | 143.61M | -61.99% |
2014 | 377.84M | 30.49% |
The current Enterprise Value of Kiora Pharmaceuticals, Inc. (KPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
46.78M
5-year avg
125.28M
10-year avg
154.39M
Kiora Pharmaceuticals, Inc.’s Enterprise Value is greater than Virax Biolabs Group Limited (4.23M), less than Blue Water Vaccines, Inc. (12.54M), greater than Revelation Biosciences, Inc. (-4075884.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Quoin Pharmaceuticals, Ltd. (-243459.00), greater than Allarity Therapeutics, Inc. (-12736306.00), less than Kiromic BioPharma, Inc. (13.21M), less than Biodexa Pharmaceuticals Plc (735.08M), less than Unicycive Therapeutics, Inc. (39.46M), less than Cardio Diagnostics Holdings, Inc. (38.12M), greater than PaxMedica, Inc. Common Stock (524.09K), less than Panbela Therapeutics, Inc. (7.83M), greater than Palisade Bio, Inc. (-2842535.00),
Company | Enterprise Value | Market cap |
---|---|---|
4.23M | $7.60M | |
12.54M | $3.41M | |
-4075884.00 | $2.47M | |
1.48M | $4.17M | |
-243459.00 | $2.87M | |
-12736306.00 | $4.39M | |
13.21M | $1.42M | |
735.08M | $927.02M | |
39.46M | $71.00M | |
38.12M | $39.38M | |
524.09K | $848.58K | |
7.83M | $1.58M | |
-2842535.00 | $4.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiora Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kiora Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kiora Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX)?
What is the 3-year average Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX)?
What is the 5-year average Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX)?
How does the current Enterprise Value for Kiora Pharmaceuticals, Inc. (KPRX) compare to its historical average?